F142-0694 Screening compound: 5-[2,4-dioxo-1-({[2-(trifluoromethyl)phenyl]carbamoyl}methyl)-1,2,3,4-tetrahydroquinazolin-3-yl]-N-(2-methylpropyl)pentanamide

F142-0694 Screening compound: 5-[2,4-dioxo-1-({[2-(trifluoromethyl)phenyl]carbamoyl}methyl)-1,2,3,4-tetrahydroquinazolin-3-yl]-N-(2-methylpropyl)pentanamide
F142-0694 Screening compound: 5-[2,4-dioxo-1-({[2-(trifluoromethyl)phenyl]carbamoyl}methyl)-1,2,3,4-tetrahydroquinazolin-3-yl]-N-(2-methylpropyl)pentanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F142-0694
5-[2,4-dioxo-1-({[2-(trifluoromethyl)phenyl]carbamoyl}methyl)-1,2,3,4-tetrahydroquinazolin-3-yl]-N-(2-methylpropyl)pentanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F142-0694

Molecular Formula

C26H29F3N4O4 (C26 H29 F3 N4 O4)

Compound Name

5-[2,4-dioxo-1-({[2-(trifluoromethyl)phenyl]carbamoyl}methyl)-1,2,3,4-tetrahydroquinazolin-3-yl]-N-(2-methylpropyl)pentanamide

IUPAC name

5-[24-dioxo-1-({[2-(trifluoromethyl)phenyl]carbamoyl}methyl)-1234-tetrahydroquinazolin-3-yl]-N-(2-methylpropyl)pentanamide

SMILES

CC(C)CNC(CCCCN(C(c(cccc1)c1N1CC(Nc2c(C(F)(F)F)cccc2)=O)=O)C1=O)=O

InChI

InChI=1S/C26H29F3N4O4/c1-17(2)15-30-22(34)13-7-8-14-32-24(36)18-9-3-6-12-21(18)33(25(32)37)16-23(35)31-20-11-5-4-10-19(20)26(27,28)29/h3-6,9-12,17H,7-8,13-16H2,1-2H3,(H,30,34)(H,31,35)

InChI Key

CSPOWWDYNNNIEU-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27104199

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

518.54

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

13.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.184

Distribution Coefficient, logD

3.184

Water Solubility, LogSw

-3.68

Polar Surface Area

78.440

Acid Dissociation Constant (pKa)

12.61

Base Dissociation Constant (pKb)

0.93

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

38.50

F142-0694 in Drug Discovery

Included in Screening Libraries

Regenerative Medicine Focused Library (23016 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with F142-0694 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F142-0694?
Check Price and Availability of F142-0694, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F142-0694 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F142-0694
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F142-0694
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F142-0694 available by request